COMMUNIQUÉ DE PRESSE
News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET
Zomedica Corp. (NYSE American: ZOM) to host conference call on April 1, 2024, discussing operational and financial highlights for Q4 and full year 2023. Company specializes in veterinary health products for companion animals -
-
-
COMMUNIQUÉ DE PRESSE
Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform
Zomedica Corp. announced the publication of a peer-reviewed research study comparing its TRUFORMA BAW diagnostic platform to CLIA platforms for feline hyperthyroidism diagnosis, showing superior accuracy and potential for early detection -
-
-
